Effect of Core Stability Versus Ankle Foot Strengthening Exercise in the Management of Knee Osteoarthritis

August 24, 2026 updated by: Shaikh Nabi Bukhsh Nazir, Dow University of Health Sciences
Knee osteoarthritis (KOA) is a degenerative joint disease causing pain, stiffness, and reduced quality of life. While treatments often focus on drugs or surgery, noninvasive exercises like core stabilization and ankle/foot strengthening show potential but lack comparative studies. Understanding anatomical factors like Achilles tendon (AT) thickness is crucial for targeted rehabilitation, though measurement reliability remains an issue. This study aims to compare the effects of these exercises on KOA symptoms and evaluate the use of digital calipers for AT thickness measurement, aiming to enhance clinical management of KOA.

Study Overview

Detailed Description

The objective of the study is:

  1. To determine the interrater and intrarater reliability of digital calliper to measure the side to side Achilles tendon thickness.
  2. To determine the impact of 24 sessions of core stability translated in gait ambulation.
  3. determines the relationships between Achilles tendon thickness (ATT), knee symptoms/functions, and foot alignment in knee OA patients, considering their interconnected biomechanical nature.
  4. compare the effects of core stability and ankle-foot strengthening exercises on clinical outcomes in KOA patients

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan
        • BIPTRM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 40 years old, had been diagnosed with KOA based on ACR, and

    • having Grade II or III osteoarthritis by K/L criteria.

Exclusion Criteria:

  • post-traumatic osteoarthritis
  • lower limb sensorimotor dysfunction,
  • Any history of knee fracture/ tumor/ infection and hip/knee surgery.
  • Total Knee Replacement patients.
  • Neurological disease.
  • Patient received physical therapy treatment from last 6 months.
  • Inflammatory Arthritis (Rheumatoid Arthritis)
  • Use of any intra-articular injections (steroid/ hyaluronic acid/ PRP.) from last 3-6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Foot-ankle strengthening exercise
resistance exercises with proper warm up and cool down
  1. Isometric quadriceps exercises involving knee extension
  2. Maximum isometric exercise for the quadriceps
Experimental: Core Stability

Core Stability exercises:

Bridging Lateral Step up etc

  1. Isometric quadriceps exercises involving knee extension
  2. Maximum isometric exercise for the quadriceps

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) at rest
Time Frame: 8 weeks
Changes from baseline, Visual Analogue Scale (VAS) is the most commonly used scale in which the pain rate ranges from 0 (no pain) to 10 (worst pain). The level of knee perception of pain is assessed by using the VAS.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: 8 weeks
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item, patient self-administered patient outcome measure designed to measure knee health in five subscales (Pain, Symptoms, Activities of Daily Living (ADL), Sport and Recreation and knee-related Quality of Life).
8 weeks
40-m fast-paced walk test
Time Frame: 8 weeks
This test was conducted as per the guideline of OARSI. The 40-meter Fast-Paced Walk Test (40m FPWT) is a brief physical performance test primarily used to measure maximum short-distance walking speed and the ability to change directions.
8 weeks
30 seconds chair stand test
Time Frame: 8 weeks
The 30-Second Chair Stand Test (or 30CST) is a quick physical test used to measure lower-body strength and endurance in adults, especially older individuals.
8 weeks
stair climb test
Time Frame: 8 weeks
Step Stair Climb Test (SCT) is a physical performance test used to evaluate functional strength, balance, and agility in individuals with mobility limitations.
8 weeks
Navicular/foot ratio
Time Frame: 8 weeks
It is calculated as the quotient of the height of the navicular tuberosity divided by the total length of the foot.
8 weeks
Achilles tendon thickness (ATT)
Time Frame: 8 weeks
measured side to side thickness using the digital calliper
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: SHAIKH NABI BUKHSH NAZIR, PhD Scholar, Dow University of Health Sciences/ Baqai Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2023

Primary Completion (Actual)

May 10, 2026

Study Completion (Actual)

May 10, 2026

Study Registration Dates

First Submitted

January 2, 2025

First Submitted That Met QC Criteria

January 4, 2025

First Posted (Actual)

January 9, 2025

Study Record Updates

Last Update Posted (Actual)

August 26, 2026

Last Update Submitted That Met QC Criteria

August 24, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • BMU/Approval?

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe